Gabapentin as Preanesthetic Medication to Fast Procedures in Pediatric´s Oncology
Pain, Postoperative, Agitation States as Acute Reaction to Exceptional Stress, Anesthesia
About this trial
This is an interventional treatment trial for Pain, Postoperative focused on measuring pediatric, gabapentin, agitation, induction
Eligibility Criteria
Inclusion Criteria:
- Cancer or under investigation for cancer.
- Children between 1 and 6 years.
- Previously submitted to oncologic procedures, e.g. myelogram or puncture lumbar.
Exclusion Criteria:
- Cardiac disease.
- Pulmonary disease.
- Renal disease.
- Neurological disease.
- Any allergies.
- Refusal of parents, caregivers or patients to participate in the study.
Sites / Locations
- Hospital Infantil Albert Sabin
Arms of the Study
Arm 1
Arm 2
Arm 3
Experimental
Experimental
Experimental
Placebo Group
GABA 15mg/kg Group
GABA 30mg/kg Group
The placebo group will receive placebo concentrate orally (0.3 mL/kg) only once, 1 to 2 hours before the oncologic procedure. All patients will undergo the same anesthetic protocol. Afterward, the patients will be submitted to oncologic procedures: Myelogram or Lumbar Puncture.
The GABA 15mg/kg group will receive gabapentin syrup orally (15 mg/kg) only once, 1 to 2 hours before the oncologic procedure. All patients will undergo the same anesthetic protocol. Afterward, the patients will be submitted to oncologic procedures: Myelogram or Lumbar Puncture.
The GABA 30mg/kg group will receive gabapentin syrup orally (30 mg/kg) only once, 1 to 2 hours before the oncologic procedure. All patients will undergo the same anesthetic protocol. Afterward, the patients will be submitted to oncologic procedures: Myelogram or Lumbar Puncture.